Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

AKTX Akari Therapeutics PLC

-0.06 (-1.8%)
Last Updated: 09:53:47
Delayed by 15 minutes


Draw Mode:

Volume 598
Bid Price 3.18
Ask Price 3.22
News -
Company Name Stock Ticker Symbol Market Type
Akari Therapeutics PLC AKTX NASDAQ Depository Receipt
  Price Change Change Percent Stock Price Last Traded
-0.06 -1.8% 3.27 09:53:47
Open Price Low Price High Price Close Price Prev Close
3.29 3.215 3.29 3.33
Trades Volume VWAP Dollar Volume Avg Volume
7 598  3.27  1,954 -
Last Trade Time Type Quantity Stock Price Currency
10:20:17 50  3.1931 USD

Akari Therapeutics PLC Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
24.34B 7.44B - 0 -17.01M -0.00 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

News Akari Therapeutics

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No AKTX Message Board. Create One! See More Posts on AKTX Message Board See More Message Board Posts

AKTX Historical

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week0.
1 Month0.
3 Months0.
6 Months0.
1 Year0.
3 Years0.
5 Years0.

Akari Therapeutics PLC is a clinical stage biopharmaceutical company. It is focused on developing inhibitors of acute and chronic inflammation which includes the complement system, the bioamine system and the eicosanoid system for the treatment of rare and orphan diseases. Its main product candidate includes Coversin, Coversin long acting and Coversin dual action. The firm earns majority of its revenues from United Kingdom. It operates mainly in United States and United Kingdom.

Your Recent History

Delayed Upgrade Clock